Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
04/2014
04/01/2014US8685939 Vaccine targeting cellular death receptor DR5
04/01/2014US8685929 Detecting CYP24 expression level as a marker for predisposition to cancer
04/01/2014US8685453 Extended-release formulation for reducing the frequency of urination and method of use thereof
04/01/2014US8685437 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
04/01/2014US8685397 Combination therapy for the treatment of ocular neovascular disorders
04/01/2014US8685384 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex
04/01/2014DE202014000988U1 Zusammensetzung zur Behandlung von thermischen Hautverbrennungen Composition for the treatment of thermal burns
04/01/2014CA2569590C Drug having regulatory cell ligand contained in liposome
04/01/2014CA2420062C Erbb4 antagonists
04/01/2014CA2405377C Nutritional modules
03/2014
03/27/2014WO2014047592A2 Compounds and compositions for use in the prevention and treatment of inflammation-related disorders, pain and fever, skin disorders, cancer and precancerous conditions thereof
03/27/2014WO2014047569A2 Product comprising a nicotine-containing material and an anti-cancer agent
03/27/2014WO2014047109A1 Pharmaceutical combination comprising a phosphatidylinositol 3-kinase inhibitor|and an aromatase inhibitor
03/27/2014WO2014046143A1 Cell-growth inhibitor screening method indexed on inhibition of nptn-s100a8 binding
03/27/2014WO2014046125A1 Prevention/treatment agent for pulmonary hypertension comprising thrombin receptor antagonist as active component
03/27/2014US20140088339 Method and System for Treatment of Cardiovascular Disorders
03/27/2014US20140088184 Use of Epigallocatechin Gallate as an Antiviral Agent against infections by the Hepatitis C Virus
03/27/2014US20140088160 Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof
03/27/2014US20140088155 d-Methadone for the Treatment of Psychiatric Symptoms
03/27/2014US20140088148 Small molecule inhibitors of xbp1 splicing
03/27/2014US20140088147 Method of inhibiting mutant c-kit
03/27/2014US20140088139 Compositions and methods of use of an inappetance-controlling compound
03/27/2014US20140088120 Modulators of Androgen Synthesis
03/27/2014US20140088117 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/27/2014US20140088110 Fused bicyclic imidazoles
03/27/2014US20140088107 Ophthalmic preparation comprising a pgf2alpha analogue
03/27/2014US20140088106 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/27/2014US20140088105 Cyclohexyl Amide Derivatives and Their Use as CRF-1 Receptor Antagonists
03/27/2014US20140088102 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
03/27/2014US20140088097 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
03/27/2014US20140088089 Cytotoxic benzodiazepine derivatives and methods of preparation
03/27/2014US20140088084 Oxazine derivatives and their use in the treatment of neurological disorders
03/27/2014US20140088083 Use of memantine (namenda) to treat autism, compulsivity, and impulsivity
03/27/2014US20140088082 Inhibitors of the plasmodial surface anion channel as antimalarials
03/27/2014US20140088077 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
03/27/2014US20140088070 Nitrogen containing compounds and their use
03/27/2014US20140088053 INHIBITORS OF 17Beta-HSD1, 17Beta-HSD3 AND 17Beta-HSD10
03/27/2014US20140088052 Chalcone derivatives as nrf2 activators
03/27/2014US20140088047 Use of long chain polyunsaturated fatty acid derivatives to treat sickle cell disease
03/27/2014US20140088045 Product comprising a nicotine-containing material and an anti-cancer agent
03/27/2014US20140088042 Proteasome Inhibitors And Methods Of Using The Same
03/27/2014US20140088016 Macrocyclic therapeutic agents and methods of treatment
03/27/2014US20140088002 Compositions and methods for treatment of diabetes
03/27/2014US20140087992 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
03/27/2014US20140087384 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
03/27/2014US20140087000 Method and System for Treatment of Biological Tissue
03/27/2014US20140086989 Protein Matrix Vaccine Compositions Including Polycations
03/27/2014US20140086987 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
03/27/2014US20140086972 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2014US20140086946 Uses of an Immunomodulatory Protein (GMI) from Ganoderma Microsporum
03/27/2014US20140086940 Herceptin® adjuvant therapy
03/27/2014US20140086938 Methods of inhibiting tumor growth using ttk antagonists
03/27/2014US20140086936 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
03/27/2014US20140086926 Method of combination therapy for prevention or treatment of c-met or angiogenesis factor induced diseases
03/27/2014US20140086910 Methods of treating or preventing alzheimer's disease using indane acetic acid derivatives
03/27/2014US20140086909 Methods and compositions for the treatment of proliferative disorders
03/27/2014US20140086908 Anti-alpha-v integrin antibody for the treatment of prostate cancer
03/27/2014US20140086907 Multimodal trail molecules and uses in cellular therapies
03/27/2014US20140086905 Immunological compositions as cancer therapeutics
03/27/2014US20140086897 Chimeric neuregulins and method of making and use thereof
03/27/2014US20140086890 Compositions and methods for treating hyperproliferative disorders
03/27/2014US20140086888 Ebv-specific cytotoxic t-lymphocytes for the treatment of locoregional nasopharyngeal carcinoma (npc)
03/27/2014US20140086873 Esters and Malonates of SATE Prodrugs
03/27/2014US20140086870 Pyrazole derivatives as jak inhibitors
03/27/2014US20140086869 Methods and compositions for treating tumors using myeloid derived suppressor cells
03/27/2014US20140086867 Systems, Compositions and Methods for the Treatment of Alopecia
03/27/2014US20140086855 Combined use of a carnosinase inhibitor with l-carnosine or its related substance and a composition containing the same
03/27/2014US20140086849 Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof
03/27/2014US20140086832 Delivery system for cytotoxic drugs by bispecific antibody pretargeting
03/27/2014US20140086830 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
03/27/2014US20140086826 Sin3b complex inhibition for preventing hematologic chemotherapy- and radiotherapy-induced cytotoxicity
03/26/2014EP2711710A1 Diagnosis of respiratory tract infectious diseases using urine specimens
03/26/2014EP2711709A1 Diagnosis of respiratory tract infectious disease using blood specimens
03/26/2014EP2711704A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
03/26/2014EP2711023A1 Osteogenesis promoter
03/26/2014EP2711017A1 Immunity inducing agent
03/26/2014EP2711009A1 Compounds for use in treating or preventing primary and metastatic breast and prostate cancer
03/26/2014EP2711008A1 N6,N6-dimethyladenosine for use in treating or preventing primary and metastatic breast cancer
03/26/2014EP2711007A1 4-Aminopyrazolo[3,4-d]pyrimidine for use in treating or preventing primary and metastatic breast and prostate cancer
03/26/2014EP2711006A1 Product Comprising a Nicotine-Containing Material and an Anti-Cancer Agent
03/26/2014EP2710893A1 Methods of treating autism spectrum disorders and compositions for same
03/26/2014EP2709991A1 Use of cxcr4 antagonists
03/26/2014EP2709606A1 Compositions containing resveratrol and essential oil of cloves for the treatment of itching
03/26/2014CN103687598A Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
03/26/2014CN103687594A Ophthalmic treatments
03/26/2014CN103667459A Application of microRNA to hypertension diagnose and antihypertension medication preparation
03/26/2014CN103667284A SiRNA for specific inhibition of COTL1 gene expression and application thereof
03/26/2014CN103667251A Method for detecting food-borne pathogenic bacteria at high throughput
03/26/2014CN103665114A Peptide and preparation method and use thereof, and pharmaceutical composition and preparation method of pharmaceutical composition
03/26/2014CN103656687A Application of NRG (neuregulin) 1beta1/ErbB4/Akt signal pathway in preparing or screening drug target for resisting Alzheimer disease neuronal loss
03/26/2014CN103656659A Targeting vector, antitumor drug and application thereof
03/26/2014CN103656653A Polyelectrolyte compound based on hyaluronic acid drug-loading nano particles, preparation method and application thereof
03/26/2014CN103656647A Effective prescription for radically treating diabetes
03/26/2014CN103656646A Anti-tumor drug composition and application thereof
03/26/2014CN103656645A Novel molecular target for treating opiate addiction and application thereof in drug development
03/26/2014CN103656644A Sugar chain-related gene and use thereof
03/26/2014CN103656643A Application of p38-STAT1 (Signal Transducer and Activator of Transcription 1) signal path conditioning agent to preparation of product for controlling HTRA1 (High Temperature Requirement A1) expression
03/26/2014CN103656642A Method and reagent for preventing and treating colorectal cancer
03/26/2014CN103656641A Transcription mesosome Med23 subunit serving as target for preventing or treating cancer
03/26/2014CN103656613A Novel method for preparing polypeptide medicinal preparation
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 1151